Keywords
Last Name
Institution

Deborah B. Marin

TitlePROFESSOR
InstitutionMount Sinai
DepartmentPsychiatry
Address1425 Madison Avenue
5th Floor Room 5-38
New York NY 10029
Phone212-659-8092
Fax212-849-2455
    Other Positions
    TitleASSOCIATE PROFESSOR
    InstitutionMount Sinai
    DepartmentGeriatrics and Palliative Medicine


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Marin D, Gabriel IH, Ahmad S, Foroni L, de Lavallade H, Clark R, O'Brien S, Sergeant R, Hedgley C, Milojkovic D, Khorashad JS, Bua M, Alsuliman A, Khoder A, Stringaris K, Cooper N, Davis J, Goldman JM, Apperley JF, Rezvani K. KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib. Leukemia. 2012 Feb; 26(2):296-302.
      View in: PubMed
    2. Lim T, Marin DB. The assessment of decisional capacity. Neurol Clin. 2011 Feb; 29(1):115-26, viii.
      View in: PubMed
    3. Goldstein HR, Marin D, Umpierre M. Chaplains and access to medical records. J Health Care Chaplain. 2011; 17(3-4):162-8.
      View in: PubMed
    4. Fellgiebel A, Keller I, Marin D, Müller MJ, Schermuly I, Yakushev I, Albrecht J, Bellhäuser H, Kinateder M, Beck M, Stoeter P. Diagnostic utility of different MRI and MR angiography measures in Fabry disease. Neurology. 2009 Jan 6; 72(1):63-8.
      View in: PubMed
    5. Perz JB, Giles C, Szydlo R, O'Shea D, Sanz J, Chaidos A, Wagner S, Davis J, Loaiza S, Marin D, Apperley J, Olavarria E, Rahemtulla A, Lampert I, Naresh K, Samson D, MacDonald D, Kanfer EJ. LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre. Bone Marrow Transplant. 2007 Jan; 39(1):41-7.
      View in: PubMed
    6. Silverman JM, Ciresi G, Smith CJ, Marin DB, Schnaider-Beeri M. Variability of familial risk of Alzheimer disease across the late life span. Arch Gen Psychiatry. 2005 May; 62(5):565-73.
      View in: PubMed
    7. Beeri MS, Silverman JM, Davis KL, Marin D, Grossman HZ, Schmeidler J, Purohit DP, Perl DP, Davidson M, Mohs RC, Haroutunian V. Type 2 diabetes is negatively associated with Alzheimer's disease neuropathology. J Gerontol A Biol Sci Med Sci. 2005 Apr; 60(4):471-5.
      View in: PubMed
    8. Marin D, Kaeda J, Szydlo R, Saunders S, Fleming A, Howard J, Andreasson C, Bua M, Olavarria E, Rahemtulla A, Dazzi F, Kanfer E, Goldman JM, Apperley JF. Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse. Leukemia. 2005 Apr; 19(4):507-12.
      View in: PubMed
    9. Marin D, Amaya K, Casciano R, Puder KL, Casciano J, Chang S, Snyder EH, Cheng I, Cuccia AJ. Impact of rivastigmine on costs and on time spent in caregiving for families of patients with Alzheimer's disease. Int Psychogeriatr. 2003 Dec; 15(4):385-98.
      View in: PubMed
    10. Grossman H, Marin D. New findings, new thinking, and new expectations in Alzheimer's disease. CNS Spectr. 2003 Nov; 8(11):804.
      View in: PubMed
    11. Marin D, Marktel S, Bua M, Szydlo RM, Franceschino A, Nathan I, Foot N, Crawley C, Na Nakorn T, Olavarria E, Lennard A, Neylon A, O'Brien SG, Goldman JM, Apperley JF. Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa. Leukemia. 2003 Aug; 17(8):1448-53.
      View in: PubMed
    12. Serby M, Brickman AM, Haroutunian V, Purohit DP, Marin D, Lantz M, Mohs RC, Davis KL. Cognitive burden and excess Lewy-body pathology in the Lewy-body variant of Alzheimer disease. Am J Geriatr Psychiatry. 2003 May-Jun; 11(3):371-4.
      View in: PubMed
    13. Zubenko GS, Zubenko WN, McPherson S, Spoor E, Marin DB, Farlow MR, Smith GE, Geda YE, Cummings JL, Petersen RC, Sunderland T. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease. Am J Psychiatry. 2003 May; 160(5):857-66.
      View in: PubMed
    14. Silverman JM, Smith CJ, Marin DB, Mohs RC, Propper CB. Familial patterns of risk in very late-onset Alzheimer disease. Arch Gen Psychiatry. 2003 Feb; 60(2):190-7.
      View in: PubMed
    15. Dugu M, Neugroschl J, Sewell M, Marin D. Review of dementia. Mt Sinai J Med. 2003 Jan; 70(1):45-53.
      View in: PubMed
    16. Widlitz M, Marin DB. Substance abuse in older adults. An overview. Geriatrics. 2002 Dec; 57(12):29-34; quiz 37.
      View in: PubMed
    17. Evers MM, Marin DB. Mood disorders. Effective management of major depressive disorder in the geriatric patient. Geriatrics. 2002 Oct; 57(10):36-40; quiz 41.
      View in: PubMed
    18. Evers MM, Samuels SC, Lantz M, Khan K, Brickman AM, Marin DB. The prevalence, diagnosis and treatment of depression in dementia patients in chronic care facilities in the last six months of life. Int J Geriatr Psychiatry. 2002 May; 17(5):464-72.
      View in: PubMed
    19. Evers MM, Purohit D, Perl D, Khan K, Marin DB. Palliative and aggressive end-of-life care for patients with dementia. Psychiatr Serv. 2002 May; 53(5):609-13.
      View in: PubMed
    20. Doraiswamy PM, Leon J, Cummings JL, Marin D, Neumann PJ. Prevalence and impact of medical comorbidity in Alzheimer's disease. J Gerontol A Biol Sci Med Sci. 2002 Mar; 57(3):M173-7.
      View in: PubMed
    21. Marin DB, Sewell MC, Schlechter A. Alzheimer's disease. Accurate and early diagnosis in the primary care setting. Geriatrics. 2002 Feb; 57(2):36-40; quiz 43.
      View in: PubMed
    22. Weinberger J, Marin DB. Brain function in aging: solutions for significant challenges. Geriatrics. 2002 Jan; 57(1):37.
      View in: PubMed
    23. Marin DB, Flynn S, Mare M, Lantz M, Hsu MA, Laurans M, Paredes M, Shreve T, Zaklad GR, Mohs RC. Reliability and validity of a chronic care facility adaptation of the Clinical Dementia Rating scale. Int J Geriatr Psychiatry. 2001 Aug; 16(8):745-50.
      View in: PubMed
    24. Aisen PS, Marin DB, Brickman AM, Santoro J, Fusco M. Pilot tolerability studies of hydroxychloroquine and colchicine in Alzheimer disease. Alzheimer Dis Assoc Disord. 2001 Apr-Jun; 15(2):96-101.
      View in: PubMed
    25. Schröder J, Buchsbaum MS, Shihabuddin L, Tang C, Wei TC, Spiegel-Cohen J, Hazlett EA, Abel L, Luu-Hsia C, Ciaravolo TM, Marin D, Davis KL. Patterns of cortical activity and memory performance in Alzheimer's disease. Biol Psychiatry. 2001 Mar 1; 49(5):426-36.
      View in: PubMed
    26. Lesser G, Kandiah K, Libow LS, Likourezos A, Breuer B, Marin D, Mohs R, Haroutunian V, Neufeld R. Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2001 Mar-Apr; 12(2):138-45.
      View in: PubMed
    27. Carney MT, Neugroschl J, Morrison RS, Marin D, Siu AL. The development and piloting of a capacity assessment tool. J Clin Ethics. 2001; 12(1):17-23.
      View in: PubMed
    28. Haroutunian V, Serby M, Purohit DP, Perl DP, Marin D, Lantz M, Mohs RC, Davis KL. Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. Arch Neurol. 2000 Aug; 57(8):1145-50.
      View in: PubMed
    29. Marin DB, Dugue M, Schmeidler J, Santoro J, Neugroschl J, Zaklad G, Brickman A, Schnur E, Hoblyn J, Davis KL. The Caregiver Activity Survey (CAS): longitudinal validation of an instrument that measures time spent caregiving for individuals with Alzheimer's disease. Int J Geriatr Psychiatry. 2000 Aug; 15(8):680-6.
      View in: PubMed
    30. Silverman JM, Smith CM, Marin DB, Schmeidler J, Birstein S, Lantz M, Davis KL, Mohs RC. Has familial aggregation in Alzheimer's disease been overestimated? Int J Geriatr Psychiatry. 2000 Jul; 15(7):631-7.
      View in: PubMed
    31. Miller SS, Marin DB. Assessing capacity. Emerg Med Clin North Am. 2000 May; 18(2):233-42, viii.
      View in: PubMed
    32. Davis KL, Mohs RC, Marin DB, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry. 1999 Nov; 56(11):981-7.
      View in: PubMed
    33. Ehrenkrantz D, Silverman JM, Smith CJ, Birstein S, Marin D, Mohs RC, Davis KL. Genetic epidemiological study of maternal and paternal transmission of Alzheimer's disease. Am J Med Genet. 1999 Aug 20; 88(4):378-82.
      View in: PubMed
    34. Haroutunian V, Purohit DP, Perl DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol. 1999 Jun; 56(6):713-8.
      View in: PubMed
    35. Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA. 1999 Apr 21; 281(15):1401-6.
      View in: PubMed
    36. Green CR, Marin DB, Mohs RC, Schmeidler J, Aryan M, Fine E, Davis KL. The impact of behavioral impairment of functional ability in Alzheimer's disease. Int J Geriatr Psychiatry. 1999 Apr; 14(4):307-16.
      View in: PubMed
    37. Silverman JM, Smith CJ, Marin DB, Birstein S, Mare M, Mohs RC, Davis KL. Identifying families with likely genetic protective factors against Alzheimer disease. Am J Hum Genet. 1999 Mar; 64(3):832-8.
      View in: PubMed
    38. Samuels SC, Silverman JM, Marin DB, Peskind ER, Younki SG, Greenberg DA, Schnur E, Santoro J, Davis KL. CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease. Neurology. 1999 Feb; 52(3):547-51.
      View in: PubMed
    39. Marin DB, Rudin E, Fox B, Neugroschl J, Brickman A, Northrop J, Fine E, Zaklad G, Morrison RS, Meier D. Feasibility of a healthcare proxy counseling program for patients with Alzheimer's disease. J Palliat Med. 1999; 2(3):323-9.
      View in: PubMed
    40. Haroutunian V, Perl DP, Purohit DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC. Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol. 1998 Sep; 55(9):1185-91.
      View in: PubMed
    41. Marin DB, Breuer B, Marin ML, Silverman J, Schmeidler J, Greenberg D, Flynn S, Mare M, Lantz M, Libow L, Neufeld R, Altstiel L, Davis KL, Mohs RC. The relationship between apolipoprotein E, dementia, and vascular illness. Atherosclerosis. 1998 Sep; 140(1):173-80.
      View in: PubMed
    42. Gabriel SM, Marin DB, Aisen PS, Lantz M, Altstiel LD, Davis KL, Mohs RC. Association of elevated alpha 1-antichymotrypsin with cognitive impairment in a prospective study of the very old. Am J Psychiatry. 1998 May; 155(5):698-700.
      View in: PubMed
    43. Marin DB, Green CR, Schmeidler J, Harvey PD, Lawlor BA, Ryan TM, Aryan M, Davis KL, Mohs RC. Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. J Am Geriatr Soc. 1997 Nov; 45(11):1331-8.
      View in: PubMed
    44. Davis KL, Marin DB, Kane R, Patrick D, Peskind ER, Raskind MA, Puder KL. The Caregiver Activity Survey (CAS): development and validation of a new measure for caregivers of persons with Alzheimer's disease. Int J Geriatr Psychiatry. 1997 Oct; 12(10):978-88.
      View in: PubMed
    45. Altstiel LD, Greenberg DA, Marin D, Lantz M, Mohs R. Apolipoprotein E genotype and cognition in the very old. Lancet. 1997 May 17; 349(9063):1451.
      View in: PubMed
    46. Li G, Aryan M, Silverman JM, Haroutunian V, Perl DP, Birstein S, Lantz M, Marin DB, Mohs RC, Davis KL. The validity of the family history method for identifying Alzheimer disease. Arch Neurol. 1997 May; 54(5):634-40.
      View in: PubMed
    47. Aisen PS, Marin D, Altstiel L, Goodwin C, Baruch B, Jacobson R, Ryan T, Davis KL. A pilot study of prednisone in Alzheimer's disease. Dementia. 1996 Jul-Aug; 7(4):201-6.
      View in: PubMed
    48. Lantz MS, Marin D. Pharmacologic treatment of agitation in dementia: a comprehensive review. J Geriatr Psychiatry Neurol. 1996 Jul; 9(3):107-19.
      View in: PubMed
    49. Marin DB, Bierer LM, Lawlor BA, Ryan TM, Jacobson R, Schmeidler J, Mohs RC, Davis KL. L-deprenyl and physostigmine for the treatment of Alzheimer's disease. Psychiatry Res. 1995 Oct 16; 58(3):181-9.
      View in: PubMed
    50. Keller MB, Klein DN, Hirschfeld RM, Kocsis JH, McCullough JP, Miller I, First MB, Holzer CP, Keitner GI, Marin DB, et al. Results of the DSM-IV mood disorders field trial. Am J Psychiatry. 1995 Jun; 152(6):843-9.
      View in: PubMed
    51. Marin DB, Kocsis JH, Frances AJ, Parides M. Desipramine for the treatment of "pure" dysthymia versus "double" depression. Am J Psychiatry. 1994 Jul; 151(7):1079-80.
      View in: PubMed
    52. Bierer LM, Knott PJ, Schmeidler JM, Marin DB, Ryan TM, Haroutunian V, Purohit DP, Perl DP, Mohs RC, Davis KL. Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptoms. Psychiatry Res. 1993 Dec; 49(3):211-7.
      View in: PubMed
    53. Frances A, Manning D, Marin D, Kocsis J, McKinney K, Hall W, Kline M. Relationship of anxiety and depression. Psychopharmacology (Berl). 1992; 106 Suppl:S82-6.
      View in: PubMed
    54. Kocsis JH, Mason BJ, Frances AJ, Sweeney J, Mann JJ, Marin D. Prediction of response of chronic depression to imipramine. J Affect Disord. 1989 Nov-Dec; 17(3):255-60.
      View in: PubMed
    55. Greenwald BS, Kramer-Ginsberg E, Marin DB, Laitman LB, Hermann CK, Mohs RC, Davis KL. Dementia with coexistent major depression. Am J Psychiatry. 1989 Nov; 146(11):1472-8.
      View in: PubMed
    56. Marin DB, Greenwald BS. Carbamazepine for aggressive agitation in demented patients during nursing care. Am J Psychiatry. 1989 Jun; 146(6):805.
      View in: PubMed
    57. Greenwald BS, Marin DB, Silverman SM. Serotoninergic treatment of screaming and banging in dementia. Lancet. 1986 Dec 20-27; 2(8521-22):1464-5.
      View in: PubMed
    Marin's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067